ConductScience.org, home

Paper4012

In vitro susceptibility studies with josamycin and erythromycin.

Strausbaugh LJ and 3 others. Antimicrob Agents Chemother, 1976. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro susceptibility studies with josamycin and erythromycin. Papers, record 4012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4012

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro susceptibility studies with josamycin and erythromycin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Strausbaugh LJL J
2Dilworth JAJ A
3Gwaltney JM JrJ M
4Sande MAM A

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
ErythromycinMajor topic
LeucomycinsMajor topic
Bacteroides fragilis
Haemophilus influenzae
Mycoplasma
Species Specificity
Staphylococcus aureus
Streptococcus pneumoniae
Streptococcus pyogenes

Source PubMed

References1

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn Papers
14,917,462Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing.Appl Microbiol1970https://conductscience.org/library/papers/4917462

Source PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
3,252,753Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3252753PubMed
3,132,382Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/3132382PubMed
2,767,221Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.Eur J Epidemiol1989https://conductscience.org/library/papers/2767221PubMed
984,809Susceptibility of anaerobic bacteria to 23 antimicrobial agents.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984809PubMed
984,786Comparative pharmacology of josamycin and erythromycin stearate.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984786PubMed
984,766In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984766PubMed
984,752In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984752PubMed
795,375Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795375PubMed
521,483Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets.J Clin Microbiol1979https://conductscience.org/library/papers/521483PubMed
324,389In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/324389PubMed
106,776In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/106776PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4012

GET https://conductscience.org/api/papers/v1/4012/authors